Risk of tuberculosis in patients with rheumatoid arthritis treated with biological and targeted drugs:meta-analysis of randomized clinical trialsOACSTPCD
Risk of tuberculosis in patients with rheumatoid arthritis treated with biological and targeted drugs:meta-analysis of randomized clinical trials
Xiaojian Ji;Feng Huang;Lidong Hu;Yiwen Wang;Siliang Man;Xingkang Liu;Chuan Song;Jiaxin Zhang;Jian Zhu;Jianglin Zhang
Department of Rheumatology and Immunology,The First Medical Center,Chinese PLA General Hospital,Beijing 100853,ChinaDepartment of Rheumatology and Immunology,The First Medical Center,Chinese PLA General Hospital,Beijing 100853,ChinaXiamen Key Laboratory of Translational Medicine for Nucleic Acid Metabolism and Regulation,Xiang'an Hospital of Xiamen University,Xiamen,Fujian 361102,ChinaDepartment of Rheumatology and Immunology,The First Medical Center,Chinese PLA General Hospital,Beijing 100853,ChinaDepartment of Rheumatology and Immunology,The First Medical Center,Chinese PLA General Hospital,Beijing 100853,ChinaDepartment of Rheumatology and Immunology,The First Medical Center,Chinese PLA General Hospital,Beijing 100853,ChinaDepartment of Rheumatology and Immunology,The First Medical Center,Chinese PLA General Hospital,Beijing 100853,ChinaDepartment of Rheumatology and Immunology,The First Medical Center,Chinese PLA General Hospital,Beijing 100853,ChinaDepartment of Rheumatology and Immunology,The First Medical Center,Chinese PLA General Hospital,Beijing 100853,ChinaDepartment of Rheumatology and Immunology,The First Medical Center,Chinese PLA General Hospital,Beijing 100853,China
Rheumatoid arthritisBiological therapyTuberculosisSystematic reviewMeta-analysisNetwork meta-analysis
Rheumatoid arthritisBiological therapyTuberculosisSystematic reviewMeta-analysisNetwork meta-analysis
《中华医学杂志(英文版)》 2022 (4)
409-415,7
评论